The results indicated that the molecular signatures (LHCGR, TNIK, and SOCS3) were associated with developmental potential from embryo to blastocyst stage and were proposed as biomarkers of embryo competence in PCOS patients. This evidence concerns the gene LHCGR and polycystic ovary syndrome.